Clinical trial Recruiting at 1 site Observational Ages 3 Months to 15

Suprazygomatic maxillary nerve block to reduce pain and shorten hospital stay after cleft palate repair in children

Official title: Length of Hospital Stay and Postoperative Analgesic Requirements After Introduction of a Specific Maxillary Nerve Block in Children Undergoing Cleft Palate Surgery: a Before-and-after Chart Review Study

Run by Karolinska Institutet · NCT07279883 · Data updated 2026-11-12

This project tries a suprazygomatic maxillary nerve block in children having cleft palate repair to see if they need less morphine and can go home sooner.

More Cleft Lip and Palate trials

Quick facts

Study typeObservational
Ages3 Months to 15 Years
SexAll
Enrollment150 (estimated)
SponsorKarolinska Institutet
Academic / other
Locations1 site (Stockholm)
StatusRecruiting
StartedJanuary 1, 2017
Main results expectedDecember 31, 2018
Study endsDecember 31, 2025
Registry record updatedDecember 12, 2025
Trial IDNCT07279883 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 3 months to 15 years who underwent cleft palate (LKG) surgery at the Karolinska center and have complete perioperative and discharge records are the ideal candidates for inclusion.

Probably not a fit

Patients outside the 3 months–15 years age range, those who did not receive the block or standard analgesia per protocol, or those with incomplete medical records are unlikely to be represented or benefit from the findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a retrospective before-and-after chart review of children aged 3 months to 15 years who underwent cleft palate repair at Astrid Lindgren Children's Hospital, Karolinska University Hospital during 2017–2018. The project compares outcomes from the period using standard systemic analgesia alone with the period after routine introduction of the suprazygomatic maxillary nerve block (SZMNB). Key outcomes include postoperative morphine requirements, opioid-related side effects, and length of hospital stay. The original evaluation began in 2018 but was interrupted by the COVID-19 pandemic and is based on available perioperative and discharge records.

Why it matters

Potential benefit: If successful, routine use of the nerve block could reduce opioid use and opioid-related side effects and enable earlier discharge after cleft palate repair.

How similar studies have gone: Previous studies and case series have reported that the suprazygomatic maxillary nerve block is a safe and effective method for analgesia in pediatric cleft palate and related procedures, so this project is a local before-and-after evaluation rather than a novel first test.

Who can join: the full rules

Show full inclusion / exclusion criteria
criteria for participating in the study

* children aged 3 months to 15 years.
* Underwent cleft palate (LKG) surgery between 2017-2018.
* Available and complete medical records including perioperative notes, anesthesia documentation, and discharge summaries.
* Received either standard systemic analgesia alone (2017) or standard analgesia plus suprazygomatic maxillary nerve block (SZMNB) (2018).

Exclusion Criteria: not fulfilling inclusion cirteria

\-

Where it's running

  • Stockholm, Sweden Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.